Clinical Trial Update: A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating QT/QTc safety and multi-dose pharmacokinetics of abiraterone acetate plus prednisone in patients with metastatic castration-resistant p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• PREDNISONE (Prednisone)
• Zytiga (abiraterone acetate)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostate Neoplasms | Phase 1 | Status: COMPLETED